The Microservices in Healthcare Market Size was valued at USD 274.08 million in 2022 and is expected to reach USD 1310 million by 2030 and grow at a CAGR of 21.6% over the forecast period 2023-2030.
The term "microservices" refers to an architectural design that enables the provision of applications like system software, which delivers functional modules with high levels of accuracy and efficiency as well as interface capabilities. These are deployable services that enable the addition of fresh methods and services to application programming interfaces (APIs). These microservices are utilized in the healthcare industry to improve business processes by controlling operations, introducing high speed, and delivering care much more effectively than the conventional method. Based on the Delivery Model and Component, healthcare microservices are categorized. Researchers, the life sciences sector, healthcare providers, and payers heavily rely on microservices in the pharmaceutical sector.
Get more information on Microservices in Healthcare Market - Request Sample Report
DRIVERS
Microservice Architecture's advantages
the capacity to accelerate project delivery
Being able to support and improve customer-focused businesses
RESTRAINTS
Security and compliance with regulations worries
Difficulty
OPPORTUNITIES
Application-Based in the Cloud
Development of IoT Applications
Microservice Architecture for Construction Applications of Real-World Evidence
CHALLENGES
Implementing Small Services Faces Organizational Challenges
Reluctance to Switch to Complex Microservice Architecture from Traditional Monolithic Architecture
Due to an increase in daily cases around the world, the market need for COVID-19 vaccination has increased. As a result, this has helped the digital healthcare platform advance interoperable medical devices, highly customized patient-specific solutions, digital twins of human systems for quicker drug discovery, clinical trials, and other initiatives. As a result, there will be a rise in the demand for microservices in healthcare technology, which will be a key subject in the post-Covid era.
The market will experience growth over the forecast period due to the rise of key companies who have unique products being released toward COVID-19. For instance, in order to combat the COVID-19 pandemic, Manorama Infosolutions introduced Telemedicine & Teleconsultation. Sharp increase in the use of cloud native software development practices. Incorporating AI into businesses, utilizing 5G and edge computing to their full potential now and in the future are all made possible by the usage of microservices, containers, and DevOps.
By Component
The healthcare microservices industry is divided into platforms and services. Consulting, integration, training, support, and maintenance services are the further sub-segments of the services segment. The market for healthcare microservices is predicted to be dominated by the platforms sector. This dominance is related to the growing demand for cloud microservice architecture for scaling services at an extremely fine level for effective system structure and optimization. Enterprise applications gain new levels of scalability thanks to the microservices architecture of cloud platforms.
By Delivery Model
On-premise and cloud-based approaches make up the different segments of the healthcare microservices industry. The market for healthcare microservices is anticipated to be dominated by the cloud-based model segment. Cloud-based microservices are offered as subscriptions that might last anywhere from one month to many years. A rising number of healthcare companies, payers, providers, and laboratories are choosing cloud-based solutions because they don't have any substantial setup costs. Subscription costs also cover maintenance and support fees, making these delivery methods more inexpensive for clients. Some further benefits of cloud-based healthcare microservices solutions include simplicity of usage and storage flexibility.
By End user
Healthcare providers, Healthcare payers, life science companies, and clinical laboratories are the segments of the healthcare microservices market. It is anticipated that the healthcare providers sector will hold the biggest market share. The adoption of microservices architecture among healthcare providers is being fueled by government programmes that assist providers in receiving incentives for the adoption of EHRs and the development of integration and connectivity solutions.
By Component
Platforms
Services
Consulting Services
Integration Services
Services
By Delivery Model
On-premise Models
Cloud-based Models
Public Cloud
Hybrid Cloud
By End-user
Healthcare Providers
Healthcare Payers
Lifesciences Industry
Research Organizations
.png)
Need any customization research on Microservices in Healthcare Market - Enquiry Now
The healthcare market for microservices is divided into four regions: North America, Asia Pacific, Europe, and the rest of the world (RoW). In 2018, North America is anticipated to rule the market. Because of the increased emphasis on enhancing the general effectiveness of healthcare organisations and the larger availability of products and services in the region, North America holds a sizable part of the global market for microservices in healthcare.
Despite the market for microservices in healthcare offering considerable development prospects, industry expansion may be constrained by worries about regulatory compliance, security, and architecture complexity.
REGIONAL COVERAGE:
North America
USA
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
The Netherlands
Rest of Europe
Asia-Pacific
Japan
South Korea
China
India
Australia
Rest of Asia-Pacific
The Middle East & Africa
Israel
UAE
South Africa
Rest of Middle East & Africa
Latin America
Brazil
Argentina
Rest of Latin America
Some of the major key players are Amazon Web Services Inc., CA Technologies, IBM Corporation, Microsoft, Software AG, NGINX Inc., Oracle Corporation, Pivotal Software, Inc., Salesforce.com, Infosys., Syntel, Inc. and other players.
| Report Attributes | Details |
|---|---|
| Market Size in 2022 | US$ 274.08 Million |
| Market Size by 2030 | US$ 1310 Million |
| CAGR |
CAGR of 21.6% From 2023 to 2030 |
| Base Year | 2022 |
| Forecast Period | 2023-2030 |
| Historical Data | 2020-2021 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Component (Platforms, Services, Consulting Services, Integration Services, Services) • By Delivery Model (On-premise Models, Cloud-based Models, Private Cloud, Public Cloud, Hybrid Cloud) • By End user (Healthcare Providers, Healthcare Payers, Lifesciences Industry, Research Organizations) |
| Regional Analysis/Coverage | North America (USA, Canada, Mexico), Europe (Germany, UK, France, Italy, Spain, Netherlands, Rest of Europe), Asia-Pacific (Japan, South Korea, China, India, Australia, Rest of Asia-Pacific), The Middle East & Africa (Israel, UAE, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America) |
| Company Profiles | Amazon Web Services Inc., CA Technologies, IBM Corporation, Microsoft, Software AG, NGINX Inc., Oracle Corporation, Pivotal Software, Inc., Salesforce.com, Infosys., Syntel, Inc. |
| Key Drivers | • Microservice Architecture's advantages • the capacity to accelerate project delivery • Being able to support and improve customer-focused businesses |
| Restraints | • Security and compliance with regulations worries • Difficulty |
Ans: The Microservices in Healthcare Market size was valued at US$ 274.08 Mn in 2022.
North America is anticipated to rule the market. Because of the increased emphasis on enhancing the general effectiveness of healthcare organisations and the larger availability of products and services in the region.
North America is anticipated to rule the market. Because of the increased emphasis on enhancing the general effectiveness of healthcare organisations and the larger availability of products and services in the region.
Microservices in Healthcare Market is divided into five segments By Component, By Delivery Model, and By End user.
Security and compliance with regulations worries are the restraints of Microservices in Healthcare Market.
Ans: The Microservices in Healthcare Market is to grow at a CAGR of 21.6% over the forecast period 2023-2030.
Table of Contents
1. Introduction
1.1 Market Definition
1.2 Scope
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges
4. Impact Analysis
4.1 COVID-19 Impact Analysis
4.2 Impact of Ukraine- Russia war
4.3 Impact of ongoing Recession
4.3.1 Introduction
4.3.2 Impact on major economies
4.3.2.1 US
4.3.2.2 Canada
4.3.2.3 Germany
4.3.2.4 France
4.3.2.5 United Kingdom
4.3.2.6 China
4.3.2.7 Japan
4.3.2.8 South Korea
4.3.2.9 Rest of the World
5. Value Chain Analysis
6. Porter’s 5 forces model
7. PEST Analysis
8. Microservices in Healthcare Market Segmentation, By Component
8.1 Platforms
8.2 Services
8.3 Consulting Services
8.4 Integration Services
8.5 Services
9. Microservices in Healthcare Market Segmentation, By Delivery Model
9.1 On-premise Models
9.2 Cloud-based Models
9.3 Private Cloud
9.4 Public Cloud
9.5 Hybrid Cloud
10. Microservices in Healthcare Market Segmentation, By End User
10.1 Healthcare Providers
10.2 Healthcare Payers
10.3 Lifesciences Industry
10.4 Research Organizations
11. Regional Analysis
11.1 Introduction
11.2 North America
11.2.1 USA
11.2.2 Canada
11.2.3 Mexico
11.3 Europe
11.3.1 Germany
11.3.2 UK
11.3.3 France
11.3.4 Italy
11.3.5 Spain
11.3.6 The Netherlands
11.3.7 Rest of Europe
11.4 Asia-Pacific
11.4.1 Japan
11.4.2 South Korea
11.4.3 China
11.4.4 India
11.4.5 Australia
11.4.6 Rest of Asia-Pacific
11.5 The Middle East & Africa
11.5.1 Israel
11.5.2 UAE
11.5.3 South Africa
11.5.4 Rest
11.6 Latin America
11.6.1 Brazil
11.6.2 Argentina
11.6.3 Rest of Latin America
12. Company Profiles
12.1 Amazon Web Services Inc.,
12.1.1 Financial
12.1.2 Products/ Services Offered
12.1.3 SWOT Analysis
12.1.4 The SNS view
12.2 CA Technologies
12.3 IBM Corporation
12.4 Microsoft, Software AG
12.5 NGINX Inc.
12.6 Oracle Corporation
12.7 Pivotal Software, Inc.
12.8 Salesforce.com
12.9 Infosys.
12.10 Syntel, Inc.
13. Competitive Landscape
13.1 Competitive Benchmark
13.2 Market Share Analysis
13.3 Recent Developments
14. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
The DNA Synthesis Market size was estimated USD 2.9 billion in 2022 and is expected to reach USD 12.2 billion by 2030 at a CAGR of 19.7% during the forecast period of 2023-2030.
The Anti-Fungal Treatment Market Size was valued at USD 15.21 billion in 2022, and is expected to reach USD 20.03 billion by 2030, and grow at a CAGR of 3.5% over the forecast period 2023-2030.
In 2022, The Cosmetic Dentistry Market size amounted to USD 33.62 Billion & is estimated to reach USD 88.11 Billion by 2030 and increase at a compound annual growth rate of 12.8% between 2023 and 2030.
The CBD Skin Care Product Market size was valued at US$ 4.17 billion in 2023 and is projected to reach US$ 24.93 billion by 2031, with a growing CAGR of 25.03% over the forecast period 2024-2031.
Artificial Tears Market size was USD 4.80 Billion in 2023 and is expected to reach USD 7.56 Billion by 2031 and grow at a CAGR of 5.18% over the forecast period of 2024-2031.
The Breast Cancer Therapeutics Market size was valued at USD 30.22 billion in 2022 and is expected to reach at USD 79.77 billion by 2030, and grow at a CAGR of 12.9% over the forecast period of 2023-2030.
Hi! Click one of our member below to chat on Phone
© 2024 All Rights Reserved by SNS Insider Pvt Ltd
